Dicot Pharma AB Statistics

Total Valuation

Dicot Pharma AB has a market cap or net worth of SEK 472.27 million. The enterprise value is 458.07 million.

Market Cap	472.27M
Enterprise Value	458.07M

Important Dates

The next estimated earnings date is Thursday, February 27, 2025.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Dicot Pharma AB has 1.78 billion shares outstanding. The number of shares has increased by 105.97% in one year.

Current Share Class	n/a
Shares Outstanding	1.78B
Shares Change (YoY)	+105.97%
Shares Change (QoQ)	+133.53%
Owned by Insiders (%)	5.86%
Owned by Institutions (%)	5.70%
Float	1.62B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	4.23
P/TBV Ratio	4.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.94
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.39

Current Ratio	10.39
Quick Ratio	9.93
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -73.93% and return on invested capital (ROIC) is -47.49%.

Return on Equity (ROE)	-73.93%
Return on Assets (ROA)	-41.84%
Return on Invested Capital (ROIC)	-47.49%
Return on Capital Employed (ROCE)	-53.09%
Revenue Per Employee	n/a
Profits Per Employee	-19.23M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.64% in the last 52 weeks. The beta is 1.39, so Dicot Pharma AB's price volatility has been higher than the market average.

Beta (5Y)	1.39
52-Week Price Change	+27.64%
50-Day Moving Average	0.28
200-Day Moving Average	0.25
Relative Strength Index (RSI)	43.62
Average Volume (20 Days)	4,174,089

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-59.30M
Pretax Income	-57.70M
Net Income	-57.70M
EBITDA	-59.29M
EBIT	-59.30M
Earnings Per Share (EPS)	-0.05

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	113.40M
Total Debt	n/a
Net Cash	113.40M
Net Cash Per Share	0.06
Equity (Book Value)	111.70M
Book Value Per Share	0.06
Working Capital	111.70M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-58.90M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Dicot Pharma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-105.97%
Shareholder Yield	-105.97%
Earnings Yield	-12.22%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a